Latest news
Heron Therapeutics Withdraws 2026 Guidance as CINVANTI Patent Risk and Strategic Review Cloud Outlook - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 15:05:39 GMTHeron Therapeutics Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 14:04:29 GMTHeron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 13:10:02 GMT